Anesi Judith A, Lautenbach Ebbing, Nachamkin Irving, Garrigan Charles, Bilker Warren B, Wheeler Mary, Tolomeo Pam, Han Jennifer H
1Division of Infectious Diseases,Department of Medicine,Perelman School of Medicine,University of Pennsylvania,Philadelphia,Pennsylvania.
4Department of Pathology and Laboratory Medicine,Perelman School of Medicine,University of Pennsylvania,Philadelphia,Pennsylvania.
Infect Control Hosp Epidemiol. 2016 Dec;37(12):1433-1439. doi: 10.1017/ice.2016.225. Epub 2016 Sep 28.
OBJECTIVE To evaluate risk factors for and molecular characteristics of community-onset extended-spectrum cephalosporin-resistant (ESC-R) Enterobacteriaceae (EB) urinary tract infections (UTIs) in a US health system. DESIGN Case-control study. PARTICIPANTS All patients presenting to the emergency department or outpatient practices with EB UTIs from December 21, 2010, through April 22, 2013, were included. Case patients had ESC-R EB UTIs. Control patients had ESC-susceptible EB UTIs and were matched 1:1 on study year. METHODS Risk factors for ESC-R EB UTI were assessed using multivariable conditional logistic regression. A subset of case isolates was evaluated for extended-spectrum beta-lactamases. RESULTS A total of 302 patients with community-onset EB UTI were included, of which 151 were cases. On multivariable analysis, risk factors for ESC-R EB UTI included trimethoprim-sulfamethoxazole use in the prior 6 months (odds ratio, 2.40 [95% CI, 1.22-4.70]; P=.01), older age (1.03 [1.01-1.04]; P<.001), diabetes (2.91 [1.32-6.41]; P=.008), and presentation to the emergency department ( 2.42 [1.31-4.46]; P=.005). The prevalence of extended-spectrum beta-lactamases among 120 case isolates was 52% CTX-M, 29% TEM, 20% OXA, and 13% SHV. The prevalence of AmpC was 25%. Pulsed-field gel electrophoresis of the CTX-M Escherichia coli isolates showed no distinct clusters. CONCLUSIONS Use of trimethoprim-sulfamethoxazole, older age, diabetes, and presentation to the emergency department were associated with community-onset ESC-R EB UTI. There was a high prevalence of CTX-M among our community isolates. Further studies are needed to determine strategies to limit emergence of these organisms in the community. Infect Control Hosp Epidemiol 2016;1433-1439.
目的 评估美国医疗系统中社区获得性产超广谱头孢菌素耐药(ESC-R)肠杆菌科细菌(EB)所致尿路感染(UTI)的危险因素及分子特征。 设计 病例对照研究。 参与者 纳入2010年12月21日至2013年4月22日期间因EB所致UTI就诊于急诊科或门诊的所有患者。病例组患者为ESC-R EB所致UTI。对照组患者为ESC敏感EB所致UTI,并按研究年份1:1匹配。 方法 使用多变量条件逻辑回归评估ESC-R EB所致UTI的危险因素。对部分病例分离株进行超广谱β-内酰胺酶评估。 结果 共纳入302例社区获得性EB所致UTI患者,其中151例为病例组。多变量分析显示,ESC-R EB所致UTI的危险因素包括前6个月使用甲氧苄啶-磺胺甲恶唑(比值比,2.40 [95%CI,1.22 - 4.70];P = 0.01)、年龄较大(1.03 [1.01 - 1.04];P < 0.001)、糖尿病(2.91 [1.32 - 6.41];P = 0.008)以及就诊于急诊科(2.42 [1.31 - 4.46];P = 0.005)。120例病例分离株中超广谱β-内酰胺酶的流行率为CTX-M 52%、TEM 29%、OXA 20%、SHV 13%。AmpC的流行率为25%。CTX-M大肠埃希菌分离株的脉冲场凝胶电泳未显示明显聚类。 结论 甲氧苄啶-磺胺甲恶唑的使用、年龄较大、糖尿病以及就诊于急诊科与社区获得性ESC-R EB所致UTI相关。我们社区分离株中CTX-M的流行率较高。需要进一步研究以确定限制这些病原体在社区出现的策略。《感染控制与医院流行病学》2016;1433 - 1439。